Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carraguard in Preventing HIV Seroconversion in Women
NCT00213083Phase 3Completed
- Sponsor
- Population Council
- Start
- Apr 2004
- Primary completion
- Apr 2007
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
Phase 3, randomised trial in human immunodeficiency virus infection (HIV) comparing Carraguard + Condom with Placebo + Condom (2 arms). Primary endpoint: Time to HIV seroconversion during trial participation. Started Apr 2004; status: completed.
02
Drugs
Carraguard
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00213083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00213083.